Detalhe da pesquisa
1.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
2.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
3.
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies.
Transfusion
; 62(11): 2391-2404, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169155
4.
Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy.
Crit Rev Biotechnol
; 36(2): 276-89, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25394539
5.
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
Nat Med
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480922
6.
Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors.
Cell Rep Med
; 4(6): 101053, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224816
7.
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction.
Cancer Discov
; 13(7): 1636-1655, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011008
8.
Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.
BMC Biotechnol
; 12: 23, 2012 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22564378
9.
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
Sci Transl Med
; 14(670): eabn7336, 2022 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350986
10.
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia.
Blood Adv
; 6(21): 5774-5785, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349631
11.
PSMA-targeting TGFß-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
Nat Med
; 28(4): 724-734, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314843
12.
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol
; 39(27): 3044-3055, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156874
13.
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
J Clin Invest
; 131(24)2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788233
14.
Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products.
Transfusion
; 50(11): 2353-61, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20492604
15.
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.
J Clin Invest
; 130(2): 673-685, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31845905
16.
CRISPR-engineered T cells in patients with refractory cancer.
Science
; 367(6481)2020 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029687
17.
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 24(5): 563-571, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713085
18.
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
JCI Insight
; 3(8)2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669947
19.
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.
J Clin Invest
; 126(2): 483-94, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26690701
20.
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 27(3): 561, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547459